60 related articles for article (PubMed ID: 2580404)
1. [Relation between the body weight of the pregnant patient and her serum alpha fetoprotein levels].
Gardó S; Wessely J
Zentralbl Gynakol; 1985; 107(1):31-4. PubMed ID: 2580404
[TBL] [Abstract][Full Text] [Related]
2. The effect of maternal weight on maternal serum alpha-fetoprotein levels.
Wald N; Cuckle H; Boreham J; Terzian E; Redman C
Br J Obstet Gynaecol; 1981 Nov; 88(11):1094-6. PubMed ID: 6170309
[TBL] [Abstract][Full Text] [Related]
3. Can low birth weight after elevated maternal serum alpha-fetoprotein be explained by maternal weight?
Haddow JE; Palomaki GE; Knight GJ
Obstet Gynecol; 1987 Jul; 70(1):26-8. PubMed ID: 2439965
[TBL] [Abstract][Full Text] [Related]
4. Fetal malformation and serum alpha-fetoprotein concentration of diabetic mothers.
Szabó M; Tóth T; Tóth Z; Szeifert GT; Csécsei K; Veress L; Papp Z
Zentralbl Gynakol; 1986; 108(20):1228-36. PubMed ID: 2433853
[TBL] [Abstract][Full Text] [Related]
5. [Significant effects on alpha-fetoprotein (AFP) concentration in maternal serum in pregnancy].
Greiff R; Schlosser H; Amse T
Zentralbl Gynakol; 1991; 113(5):253-7. PubMed ID: 1711749
[TBL] [Abstract][Full Text] [Related]
6. [Increased AFP in maternal serum as an indication for invasive diagnosis].
Gremm B; Sohn C; Beldermann F; Bastert G
Zentralbl Gynakol; 1997; 119(11):560-6. PubMed ID: 9480612
[TBL] [Abstract][Full Text] [Related]
7. Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?
Sancken U; Bartels I
Prenat Diagn; 2001 May; 21(5):383-6. PubMed ID: 11360279
[TBL] [Abstract][Full Text] [Related]
8. The inadequacy of the current correction for maternal weight in maternal serum alpha-fetoprotein interpretation.
Drugan A; Dvorin E; Johnson MP; Uhlmann WR; Evans MI
Obstet Gynecol; 1989 Nov; 74(5):698-701. PubMed ID: 2478941
[TBL] [Abstract][Full Text] [Related]
9. Very low alpha-fetoprotein in Down syndrome maternal serum screening.
Muller F; Dreux S; Sault C; Galland A; Puissant H; Couplet G; Lemay C; Larcher ME; Renom G;
Prenat Diagn; 2003 Jul; 23(7):584-7. PubMed ID: 12868089
[TBL] [Abstract][Full Text] [Related]
10. Fetal serum alpha-fetoprotein in alloimmunised pregnancies.
Bartha JL; Harrison G; Kyle PM; Soothill PW
Prenat Diagn; 2003 Nov; 23(11):917-20. PubMed ID: 14634978
[TBL] [Abstract][Full Text] [Related]
11. Maternal and fetal serum transformed alpha-fetoprotein levels in normal pregnancy.
González-Bugatto F; Foncubierta E; Bailén Mde L; Illanes S; Hervías-Vivancos B; Bartha JL
J Obstet Gynaecol Res; 2009 Apr; 35(2):271-6. PubMed ID: 19453690
[TBL] [Abstract][Full Text] [Related]
12. Decreased alpha-fetoprotein in amniotic fluid and maternal serum in diabetic pregnancy.
Henriques CU; Damm P; Tabor A; Pedersen JF; Mølsted-Pedersen L
Obstet Gynecol; 1993 Dec; 82(6):960-4. PubMed ID: 7694215
[TBL] [Abstract][Full Text] [Related]
13. Maternal serum markers levels in consecutive pregnancies: a possible genetic predisposition to abnormal levels.
Dar H; Merksamer R; Berdichevsky D; David M
Am J Med Genet; 1996 Jan; 61(2):154-7. PubMed ID: 8669443
[TBL] [Abstract][Full Text] [Related]
14. Co-variables in first trimester maternal serum screening.
de Graaf IM; Cuckle HS; Pajkrt E; Leschot NJ; Bleker OP; van Lith JM
Prenat Diagn; 2000 Mar; 20(3):186-9. PubMed ID: 10719318
[TBL] [Abstract][Full Text] [Related]
15. Prenatal diagnosis of neural tube defects. IV. Maternal serum alpha-fetoprotein screening.
Milunsky A; Alpert E; Neff RK; Frigoletto FD
Obstet Gynecol; 1980 Jan; 55(1):60-6. PubMed ID: 6153240
[TBL] [Abstract][Full Text] [Related]
16. Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong.
Lam YH; Ghosh A; Tang MH; Tang LC; Lee CP; Sin SY; Ho PK
Prenat Diagn; 1998 Jun; 18(6):585-89. PubMed ID: 9664604
[TBL] [Abstract][Full Text] [Related]
17. [Prenatal maternal blood screening for the detection of fetal chromosomal abnormalities: clinical importance of the rate of false positives].
Alvarez-Nava F; Soto M; Padrón T; Morales A; Villalobos D; Rojas de Atencio A; Prieto M; Martínez MC
Invest Clin; 2003 Sep; 44(3):195-207. PubMed ID: 14552058
[TBL] [Abstract][Full Text] [Related]
18. Transformed alpha-fetoprotein (t-AFP) levels in women with threatened preterm labor.
González-Bugatto F; Bailén Mde L; Fernández-Macías R; Fernández-Deudero A; Hervías-Vivancos B; Bartha JL
Gynecol Obstet Invest; 2009; 68(3):199-204. PubMed ID: 19672090
[TBL] [Abstract][Full Text] [Related]
19. Maternal serum transformed alpha-fetoprotein levels in women with intrauterine growth retardation.
Bartha JL; Illanes S; González-Bugatto F; Abdel-Fattah SA; Mizejewski GJ; Soothill PW
Fetal Diagn Ther; 2007; 22(4):294-8. PubMed ID: 17361083
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
